Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes Mellitus

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJerash Private University

About this trial

This randomized controlled trial aims to evaluate the effectiveness of a self-efficacy-based educational program on glycemic self-monitoring, diabetes self-management knowledge, and health-related quality of life among adults with Type 2 Diabetes Mellitus. Participants will be randomly assigned to either an intervention group receiving the educational program or a control group receiving standard care.

The educational program is designed to enhance patients' confidence (self-efficacy) in managing their condition, including blood glucose monitoring, adherence to treatment, lifestyle modification, and self-care practices. Outcomes will be assessed using validated tools to measure improvements in self-monitoring behaviors, knowledge, and quality of life.

The findings of this study are expected to provide evidence on the effectiveness of educational interventions in improving diabetes management and patient outcomes.

Eligibility criteria

Qualifiers

Adults aged 18 years and above

Diagnosed with Type 2 Diabetes Mellitus (T2DM)

Attending Jordanian Ministry of Health healthcare facilities for at least six months with regular follow-up visits

Able to perform or learn self-monitoring of blood glucose (SMBG)

Disqualifiers

Patients with Type 1 diabetes mellitus or gestational diabetes

Patients with physical or cognitive impairments that limit the ability to perform SMBG independently

Pregnant or lactating women

Patients with severe medical conditions such as renal failure or cardiovascular instability that may affect participation

Trial design

Treatments tested in this trial

  • Self-Efficacy-Based Educational Program

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators